ONCY
Oncolytics Biotech
ONCY
ONCY
21 hedge funds and large institutions have $707K invested in Oncolytics Biotech in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
+1
Holders Change %
+5%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Renaissance Technologies
New York
|
+$61K |
2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$51.5K |
3 |
Morgan Stanley
New York
|
+$24.6K |
4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$12.9K |
5 |
IP
Intellectus Partners
San Francisco,
California
|
+$8K |
Top Sellers
1 |
Millennium Management
New York
|
-$1.71M |
2 |
Citigroup
New York
|
-$5K |
3 |
SEI Investments
Oaks,
Pennsylvania
|
-$4K |
4 |
Bank of America
Charlotte,
North Carolina
|
-$3.81K |
5 |
JFA
JNBA Financial Advisors
Bloomington,
Minnesota
|
-$1K |